Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Oral presentation

Evidence for synovial fibroblasts spreading rheumatoid arthritis

Authors: Ulf Müller-Ladner, Stefanie Lefèvre, Birgit Zimmermann, Ingo H Tarner, Robert Dinser, Thomas Pap, Steffen Gay, Elena Neumann

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

Active rheumatoid arthritis (RA) is characterized by continuous progression of the inflammatory process, eventually affecting the majority of joints. Thus far, molecular and cellular pathways of disease progression are largely unknown. One of the key players in this destructive scenario are synovial fibroblasts (SF) which actively attach to, invade into and degrade articular cartilage. As RASF are able to migrate in vitro, the current series of experiments were designed to evaluate the potential of RASF to spread the disease in vivo in the SCID mouse model of RA. …
Metadata
Title
Evidence for synovial fibroblasts spreading rheumatoid arthritis
Authors
Ulf Müller-Ladner
Stefanie Lefèvre
Birgit Zimmermann
Ingo H Tarner
Robert Dinser
Thomas Pap
Steffen Gay
Elena Neumann
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3570

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue

Oral presentation

Etiology and molecular pathogenesis of RA; how can we best use European initiatives to advance our knowledge?

Poster presentation

Abnormal expressions of immune response-related genes in RA bone marrow cells

Poster presentation

Adrenal function in rheumatoid arthritis: a correlation with disease activity

Oral presentation

Autoimmune arthritis caused by altered thymic T-cell selection due to a mutation of the ZAP-70 gene

Oral presentation

From rheumatic diseases to cancer - role of autoantibodies as diagnostic biomarkers

Poster presentation

The association of autoantibodies expression, Th1/Th2 cytokines balance and IFNG polymorphism with histological phenotype of lupusnephritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits